HB7189, titled the PrEP Access Act, would amend Medicare to cover certain HIV prevention services when they are furnished by pharmacists. The bill defines these services broadly to include evaluation, management, screening, consultation, and counseling related to pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), other evidence-based HIV prevention interventions, medication administration, and related clinical diagnostic laboratory tests, so long as the pharmacist is authorized to provide the service under state law.
The bill also sets a Medicare payment rule for these pharmacist-provided HIV prevention services: Medicare would pay 80 percent of the lesser of the actual charge or 85 percent of the amount otherwise determined under the physician fee schedule. It further extends Medicare’s balance-billing protections to pharmacists providing these services and makes a conforming change so that only services that are not reasonable and necessary for HIV prevention or detection remain excluded from coverage. The amendments would apply to services furnished on or after January 1, 2027.
Impact
If enacted, the bill would amend multiple provisions of Title XVIII of the Social Security Act, expanding the scope of covered Medicare Part B services to include pharmacist-delivered HIV prevention care. It would affect Medicare beneficiaries, pharmacists, and providers involved in HIV prevention by allowing reimbursement for PrEP-related and other HIV prevention services in pharmacy settings, while tying coverage to state scope-of-practice law and existing Medicare medical-necessity standards.
Sentiment
Based on the bill text and available context, the measure appears to be framed as a public health access expansion with no recorded committee debate or votes in the provided materials. The introduction by a group of Democratic members suggests support from sponsors who favor broader access to HIV prevention services, especially through pharmacists as accessible frontline providers. No opposing statements, amendments, or recorded roll-call votes are included in the available record.
Contention
The main policy issues likely concern whether Medicare should reimburse pharmacists directly for HIV prevention services and how far pharmacist scope of practice should extend under state law. Potential points of contention include payment levels, the use of pharmacists instead of physicians or other clinicians, and whether expanding coverage could create administrative or regulatory complexity for Medicare and states. Because no committee transcript or vote history is provided, no specific opponents are identified in the record.
Relating to the regulation of pharmacists and the practice of pharmacy, including the administration of a medication and the ordering and administration of an immunization or vaccination by a pharmacist.